Delaware (State or Other Jurisdiction of Incorporation) |
001-33528 (Commission File Number) |
75-2402409 (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.07 | Submission of Matters to a Vote of Security Holders. |
1. | All ten nominees were elected to the Board of Directors with each director receiving votes as follows: |
Election of Directors | For | Withheld | ||||||
Phillip Frost, M.D. |
221,889,670 | 4,424,586 | ||||||
Jane H. Hsiao, Ph.D. |
218,143,423 | 8,170,833 | ||||||
Steven D. Rubin |
216,903,397 | 9,410,859 | ||||||
Robert A. Baron |
222,133,205 | 4,181,051 | ||||||
Thomas E. Beier |
222,891,955 | 3,422,301 | ||||||
Pascal J. Goldschmidt, M.D. |
213,093,462 | 13,220,794 | ||||||
Richard A. Lerner, M.D |
225,804,665 | 509,591 | ||||||
John A. Paganelli |
216,926,432 | 9,387,824 | ||||||
Richard C. Pfenniger, Jr. |
217,405,070 | 8,909,186 | ||||||
Alice Lin-Tsing Yu, M.D., Ph.D. |
213,088,445 | 13,225,811 |
2. | The approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company (Say On Pay) as disclosed in the Companys Proxy Statement for the 2011 Annual Meeting of Stockholders, pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables, and any related information found in the proxy statement. The votes on this proposal were as follows: |
For | Against | Abstain | ||
224,633,985
|
682,004 | 993,266 |
3. | The selection of three years, on a non-binding advisory basis, as the frequency with which the stockholders are provided a non-binding advisory vote on Say on Pay in future years. The votes on this proposal were as follows: |
3 Years | 2 Years | 1 Year | Abstain | |||
202,362,708 | 453,397 | 22,448,646 | 1,049,504 |
No other matters were considered or voted upon at the meeting. |
ITEM 7.01 | Regulation FD Disclosure. |
ITEM 9.01 | Financial Statements and Exhibits. |
Exhibit | ||||
No. | Description | |||
99.1 | Management Presentation 2011 Annual Meeting of Stockholders held June 9, 2011. |
OPKO Health, Inc. |
||||
By | /s/Adam Logal | |||
Name: | Adam Logal | |||
Title: | Executive Director of Finance, Chief Accounting Officer Treasurer |
|||
Exhibit | ||||
No. | Description | |||
99.1 | Management Presentation 2011 Annual Meeting of Stockholders held June 9, 2011. |